Chordate Medical Holding AB (ST:CMH) — Market Cap & Net Worth
Market Cap & Net Worth: Chordate Medical Holding AB (CMH)
Chordate Medical Holding AB (ST:CMH) has a market capitalization of $29.05K (Skr269.96K) as of May 4, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #31187 globally and #743 in its home market, demonstrating a -74.55% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Chordate Medical Holding AB's stock price Skr0.10 by its total outstanding shares 2699620 (2.70 Million). Analyse Chordate Medical Holding AB cash flow conversion to see how efficiently the company converts income to cash.
Chordate Medical Holding AB Market Cap History: 2022 to 2026
Chordate Medical Holding AB's market capitalization history from 2022 to 2026. Data shows change from $57.48 Million to $29.05K (-86.42% CAGR).
Chordate Medical Holding AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Chordate Medical Holding AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.92x
Chordate Medical Holding AB's market cap is 3.92 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $57.48 Million | $108.52K | -$27.94 Million | 529.66x | N/A |
| 2023 | $17.70 Million | $976.28K | -$29.19 Million | 18.13x | N/A |
| 2024 | $2.61 Million | $664.69K | -$27.25 Million | 3.92x | N/A |
Competitor Companies of CMH by Market Capitalization
Companies near Chordate Medical Holding AB in the global market cap rankings as of May 4, 2026.
Key companies related to Chordate Medical Holding AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Chordate Medical Holding AB Historical Marketcap From 2022 to 2026
Between 2022 and today, Chordate Medical Holding AB's market cap moved from $57.48 Million to $ 29.05K, with a yearly change of -86.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr29.05K | -86.81% |
| 2025 | Skr220.22K | -91.56% |
| 2024 | Skr2.61 Million | -85.26% |
| 2023 | Skr17.70 Million | -69.21% |
| 2022 | Skr57.48 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Chordate Medical Holding AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $29.05K USD |
| MoneyControl | $29.05K USD |
| MarketWatch | $29.05K USD |
| marketcap.company | $29.05K USD |
| Reuters | $29.05K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Chordate Medical Holding AB
Chordate Medical Holding AB (publ), a medical technology company, engages in the development of products and solutions for neurostimulation treatment in Sweden. It offers Ozilia, a neuromodulation and medication-free treatment technology for chronic migraine and chronic rhinitis. The company was founded in 2005 and is based in Kista, Sweden.